Hanx Biopharmaceuticals Proposes General Mandate to Repurchase H Shares at Upcoming EGM
I'm PortAI, I can summarize articles.
Hanx Biopharmaceuticals (Wuhan) Co. Ltd. has proposed a general mandate to repurchase H shares, which will be voted on at an extraordinary general meeting on February 12, 2026. Shareholders are encouraged to seek professional advice regarding their voting decisions.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments